Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On August 12, 2024, Macquarie downgraded Piedmont Lithium to Neutral from Outperform, citing concerns over the Company’s cash generation capabilities and financial commitments. Specifically, Macquarie concluded that the Company’s North American Lithium operation is challenged due to high production costs and low realized lithium prices, placing its only cash generation source at risk.
Following this news, Piedmont Lithium’s stock price fell over 11% the same day.
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
NVO | Novo Nordisk A/S | March 25, 2025 | Join |
GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
NEM | Newmont Corporation | April 01, 2025 | Join |
GSK | GSK plc | April 07, 2025 | Join |
NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
MRK | Merck & Co., Inc. | April 14, 2025 | Join |